PATENT CLAIM ANALYSIS

Application Number: 15746806
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-12
Patent Classification: ["514", "04400A"]

Abstract:
The present invention relates to the combination of a PARP inhibitor with a Dbait molecule for treating cancer.

Claim (Index 3):
A kit comprising a PARP inhibitor and a nucleic acid molecule as a combined preparation for simultaneous, separate or sequential use, in particular for use in the treatment of cancer, wherein the nucleic acid molecule is a hairpin nucleic acid with a double-stranded DNA stem and a loop and has one of the following formulae: wherein N is a deoxynucleotide, n is an integer from 23 to 195, the underlined N refers to a nucleotide having or not a modified phosphodiester backbone, L\u2032 is a linker, C is the molecule facilitating endocytosis selected from a lipophilic molecule or a ligand which targets cell receptor enabling receptor mediated endocytosis, L is a linker, m and p, independently, are an integer being 0 or 1, and wherein the nucleic acid molecule has less than 70% sequence identity to any gene in a human genome.

Metadata:
- Claim Count in Document: 67.0
- Percentile: 86.0
- Lexical Diversity: 1.05556
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13703965', '14118583', '15632951', '15232844', '14923482']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8286066251106746
- 35 USC 102 Novelty (BERT): 0.5777114350358
- Combined Prediction Score: 0.8035171061031872
- Mean Citation Score: 480.07088600000014
- Max Citation Score: 505.55835
- Similarity Product: 404.883714002645

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test